- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01207609
Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
A Prospective Study to Evaluate the Safety and Efficacy of the Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
The purpose of this study is to collect data prospectively on the safety and efficacy of the Laparoscopic Gastric Plication operation for patients with Severe or Morbid Obesity.
The 95% confidence interval for average percentage of weight loss and body mass index will be computed at 6 months, one year and then annually. Analysis of comorbid conditions changes, quality of life and adverse events will be performed. With 50 subjects in the study, limited power is expected and no formal hypothesis testing will be performed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Dalton, Georgia, United States, 30722
- Hamilton Medical Center
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37421
- Chattanooga Bariatrics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 18 - 60 years
- BMI 35-39.9 kg/m2 with one or more severe co-morbid conditions or BMI 40-55 kg/m2
- Willingness to comply with dietary restrictions required by the protocol
- History of obesity for at least 5 years
- History of at least 6 months of documented failures with traditional non-surgical weight loss methods
- Willingness to follow protocol requirements which include: signing the informed consent form, completing routine follow-up visits for the study duration, and completing all pre- and post-operative laboratory and diagnostics tests in addition to the quality of life questionnaire
- If female with childbearing potential, using an appropriate form of contraception
Exclusion Criteria:
- Age less than 18, age greater than 60
- Pregnancy
- History of major depressive disorder or psychosis
- Previous bariatric surgery or previous gastric surgery
- Presence of achalasia
- Any condition that, in the judgment of the investigator, would place a subject at undue risk, or could potentially compromise the results or interpretation of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Laparoscopic Gastric Plication
Collect data prospectively on the safety and efficacy of the Laparoscopic Gastric Plication operation for 50 patients with Severe or Morbid Obesity
|
The procedure is performed laparoscopic.
The greater curvature of the stomach is separated from the greater omentum using a harmonic scalpel starting approximately 3-5 cm from the pylorus and ending at the angle of His.
As needed, adhesions to the posterior surface of the stomach may be transected.
At least two rows stitches will be placed laparoscopically about the greater curvature of the stomach starting at or near the angle of His and ending in the antrum.
A calibration tube or endoscope will be used to maintain a lumen during the procedure, ensuring one exists after the procedure.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of excess weight loss
Time Frame: 3 years
|
The primary efficacy variable is weight loss, which is measured in pounds and evaluated in terms of % excess weight loss (EWL) and body mass index (BMI), both of which will be measured at each follow-up visit. Percent EWL is calculated by the following equation: [Weight Lost]/ [(Pre-op Weight)-(Ideal Body Weight)]. BMI is calculated by the equation: Weight (kg) divided by Height (m) squared [kg/m2]. |
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Status of comorbid conditions
Time Frame: 3 years
|
Improvement, resolution or worsening of pre-operative co-morbidities will be evaluated and reported at one year and annually up to 3 years.
Status will be evaluated according to the necessity of medications to maintain normal physiologic values such as fasting serum glucose in diabetic patients, normal blood pressure in hypertensive patients, and use of a CPAP machine for patients with obstructive sleep apnea.
|
3 years
|
|
Changes in quality of life scores from base line
Time Frame: 3 years
|
Status of quality of life will be evaluated objectively with a standardized SF-36 Health Survey
|
3 years
|
|
Adverse events
Time Frame: 3 years
|
Adverse events are intended to be volunteered by subjects or observed by the investigator.
All adverse events are to be recorded on appropriate case report forms.
|
3 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jaime Ponce, MD, Hamilton Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-9-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbid Obesity
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Sohag UniversityActive, not recruitingMorbid Obesity Requiring Bariatric SurgeryEgypt
-
General Committee of Teaching Hospitals and Institutes...CompletedMorbid Obesity Requiring Bariatric SurgeryEgypt
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Yongtao SunThe First Hospital affiliated of Shandong First Medical UniversityNot yet recruiting
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Laval UniversityInstitut universitaire de cardiologie et de pneumologie de Québec, University...Recruiting
-
Husson UniversityCompletedMorbid Obesity
Clinical Trials on Laparoscopic Gastric Plication
-
Virginia Commonwealth UniversityChildren's Hospital of RichmondCompletedObesityUnited States
-
Northwell HealthCompletedMorbid ObesityUnited States
-
Baystate Medical CenterTerminatedMorbid ObesityUnited States
-
Institute for Clinical and Experimental MedicineNot yet recruiting
-
University Hospital OstravaUniversity of Ostrava; Vitkovice Hospital, Ostrava, Czech RepublicCompleted
-
Assistance Publique Hopitaux De MarseilleTerminatedMorbid Obesity | Bariatric SurgeryFrance
-
Tenet Healthcare CorporationUnknown
-
University of California, San FranciscoWithdrawnWeight Loss | Morbid Obesity | Complex Incisional HerniasUnited States
-
Mansoura UniversityUnknown
-
NYU Langone HealthWithdrawn